DK1776587T3 - Anvendelse af C3a og derivater deraf som biomarkör for colorektalt adenom og/eller carcinom, diagnosemetoder og assays under anvendelse deraf - Google Patents

Anvendelse af C3a og derivater deraf som biomarkör for colorektalt adenom og/eller carcinom, diagnosemetoder og assays under anvendelse deraf

Info

Publication number
DK1776587T3
DK1776587T3 DK05772471T DK05772471T DK1776587T3 DK 1776587 T3 DK1776587 T3 DK 1776587T3 DK 05772471 T DK05772471 T DK 05772471T DK 05772471 T DK05772471 T DK 05772471T DK 1776587 T3 DK1776587 T3 DK 1776587T3
Authority
DK
Denmark
Prior art keywords
colorectal
carcinoma
colorectal adenoma
biomarker
adenoma
Prior art date
Application number
DK05772471T
Other languages
English (en)
Inventor
Kerstin David
Anne-Kristin Fentz
Hartmut Juhl
Original Assignee
Indivumed Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34958684&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1776587(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Indivumed Gmbh filed Critical Indivumed Gmbh
Application granted granted Critical
Publication of DK1776587T3 publication Critical patent/DK1776587T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57535—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the large intestine, e.g. colon, rectum or anus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57585—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds identifiable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/78—Thyroid gland hormones, e.g. T3, T4, TBH, TBG or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/76—Assays involving albumins other than in routine use for blocking surfaces or for anchoring haptens during immunisation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Endocrinology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK05772471T 2004-08-13 2005-08-11 Anvendelse af C3a og derivater deraf som biomarkör for colorektalt adenom og/eller carcinom, diagnosemetoder og assays under anvendelse deraf DK1776587T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/EP2004/009124 WO2006015616A1 (en) 2004-08-13 2004-08-13 Use of transthyretin as a biomarker for colorectal adenoma and/or carcinoma; method for detection and test system
PCT/EP2005/008742 WO2006053592A1 (en) 2004-08-13 2005-08-11 Use of c3a and derivatives thereof as a biomarker for colorectal ademona and/or carcinoma; diagnosis method and test system using the same

Publications (1)

Publication Number Publication Date
DK1776587T3 true DK1776587T3 (da) 2009-04-20

Family

ID=34958684

Family Applications (2)

Application Number Title Priority Date Filing Date
DK04764118T DK1761779T3 (da) 2004-08-13 2004-08-13 Anvendelse af transthyretin som en biomarkör for colorectalt adenom; fremgangsmåde til bestemmelse og testsystem
DK05772471T DK1776587T3 (da) 2004-08-13 2005-08-11 Anvendelse af C3a og derivater deraf som biomarkör for colorektalt adenom og/eller carcinom, diagnosemetoder og assays under anvendelse deraf

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK04764118T DK1761779T3 (da) 2004-08-13 2004-08-13 Anvendelse af transthyretin som en biomarkör for colorectalt adenom; fremgangsmåde til bestemmelse og testsystem

Country Status (20)

Country Link
US (2) US7951528B2 (da)
EP (3) EP1843159A1 (da)
JP (2) JP4916441B2 (da)
KR (1) KR20070051328A (da)
CN (2) CN101014859A (da)
AT (2) ATE376674T1 (da)
AU (2) AU2004322162B2 (da)
BR (1) BRPI0419002A (da)
CA (2) CA2577601A1 (da)
DE (2) DE602004009716T2 (da)
DK (2) DK1761779T3 (da)
ES (2) ES2295907T3 (da)
IL (2) IL181131A (da)
MX (2) MX2007001479A (da)
NO (2) NO20070598L (da)
PL (2) PL1761779T3 (da)
PT (2) PT1761779E (da)
SI (1) SI1776587T1 (da)
WO (2) WO2006015616A1 (da)
ZA (1) ZA200701188B (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1761779E (pt) * 2004-08-13 2008-02-01 Indivumed Gmbh Utilização de transtirretina como um biomarcador de adenoma colorrectal; método de detecção e sistema de teste
EP1775590A1 (en) * 2005-10-11 2007-04-18 Laboratorios S.A.L.V.A.T., S.A. Non-invasive in vitro method to detect transitional cell carcinoma of the bladder
JP4748671B2 (ja) * 2006-03-16 2011-08-17 日東紡績株式会社 食道扁平上皮癌マーカーおよびそれを利用した食道扁平上皮癌の判定方法
KR100819122B1 (ko) 2006-09-30 2008-04-04 남명진 췌장암 진단용 키트
WO2009025080A1 (ja) * 2007-08-18 2009-02-26 School Juridical Person Kitasato Institute 大腸癌マーカポリペプチド、及び大腸癌の診断方法
JP5203687B2 (ja) * 2007-12-12 2013-06-05 シスメックス株式会社 動物検査情報提供システム、中央装置、動物検査情報提供方法及びコンピュータプログラム
CN101838683B (zh) * 2008-12-12 2013-09-18 深圳华大基因科技有限公司 一种kras基因和/或braf基因的核苷酸突变位点的检测方法
CN102147396B (zh) * 2010-02-10 2014-01-01 桑建利 人血液样本中脂类分子含量测定及其结直肠腺瘤诊断试剂盒制备与应用
JP2013253780A (ja) * 2010-10-12 2013-12-19 Katakura Industries Co Ltd うつ病の診断のためのデータの提供方法
US10158898B2 (en) 2012-07-26 2018-12-18 Comcast Cable Communications, Llc Customized options for consumption of content
WO2014085826A2 (en) * 2012-11-30 2014-06-05 Applied Proteomics, Inc. Method for evaluation of presence of or risk of colon tumors
CN104056277B (zh) * 2013-03-21 2019-07-05 中国人民解放军第二军医大学 Mlh1基因或其表达产物在dkk4高表达的结直肠癌中的应用
CA2943827A1 (en) * 2014-03-28 2015-10-01 Applied Proteomics, Inc. Protein biomarker profiles for detecting colorectal tumors
EP3183578B8 (en) * 2014-08-22 2020-07-15 Abbott Laboratories Methods for the early detection of colorectal cancer
CN105988006A (zh) * 2015-02-10 2016-10-05 张曼 尿液补体c3蛋白的应用
WO2016164815A1 (en) 2015-04-10 2016-10-13 Applied Proteomics, Inc. Protein biomarker panels for detecting colorectal cancer and advanced adenoma
US20180092874A1 (en) * 2016-10-03 2018-04-05 Lincoln Memorial University Identification and use of very long chain dicarboxylic acids for disease diagnosis, chemoprevention, and treatment
KR102018205B1 (ko) * 2017-07-24 2019-09-05 (주) 바이오인프라생명과학 대장암 진단용 조성물 및 상기 조성물을 이용한 대장암 진단 방법
GB201721569D0 (en) * 2017-12-21 2018-02-07 Belgian Volition Sprl Method for the detection and treatment of colorectal adenomas
GB201808476D0 (en) * 2018-05-23 2018-07-11 Univ Liverpool Biomarkers for colorectal cancer
EP4041888A4 (en) 2019-10-11 2023-11-01 Guardant Health, Inc. USE OF CELLULAR BACTERIAL NUCLEIC ACIDS FOR CANCER DETECTION
EP4407042A3 (en) 2020-07-10 2024-09-18 Guardant Health, Inc. Methods of detecting genomic rearrangements using cell free nucleic acids
WO2023282916A1 (en) 2021-07-09 2023-01-12 Guardant Health, Inc. Methods of detecting genomic rearrangements using cell free nucleic acids
US20230280349A1 (en) * 2022-03-01 2023-09-07 The University Of Chicago Methods of Differentiating a Malignant Tumor from a Non-Malignant Tumor
CN116449018B (zh) * 2023-02-14 2023-09-05 浙江大学 一种用于肠腺瘤腺癌诊断的血浆蛋白标记物及应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4996298A (en) * 1988-04-20 1991-02-26 New England Deaconess Hospital Corporation Marker for colorectal carcinoma and methods of detecting the same
US5654161A (en) 1995-05-12 1997-08-05 Chiron Diagnostics Corporation Method for diagnosing prostate cancer
US6221621B1 (en) 1997-03-06 2001-04-24 Bard Diagnostic Sciences, Inc. Methods of screening for colorectal cancers in which a complement Factor I or related protein is associated
DE19711111C2 (de) 1997-03-06 1999-09-02 Schering Ag In vitro Nachweis zur Erkennung von Darmtumoren
IL121134A0 (en) * 1997-06-22 1997-11-20 Yeda Res & Dev Peptides and antiallergic compositions comprising them
WO2002059621A2 (en) 2001-01-24 2002-08-01 Bayer Corporation Regulation of transthyretin to treat obesity
AU2002316299A1 (en) 2001-06-22 2003-01-08 Merck And Co., Inc. Ppar-alpha ligands for the treatment or prevention of cachexia
US7144708B2 (en) * 2001-06-25 2006-12-05 The Cleveland Clinic Foundation Markers of blood barrier disruption and methods of using same
DE10224534A1 (de) 2002-05-31 2003-12-11 Juergen Dolderer Verfahren zum Diagnostizieren des colorektaien Karzinoms in einer Gewebeprobe und Mittel zur Behandlung
AU2002349786A1 (en) 2002-06-19 2004-01-06 Japan As Represented By The President Of The University Of Tokyo Method for diagnosis of colorectal tumors
NZ562192A (en) * 2002-08-06 2009-07-31 Ciphergen Biosystems Inc Use of biomarkers for detecting ovarian cancer
US20070117164A1 (en) * 2003-04-08 2007-05-24 Raskov Hans H Method for detection of colorectal cancer in human samples
US7268117B2 (en) * 2003-07-11 2007-09-11 Praecis Pharmaceuticals Incorporated Compositions, kits, and methods for identification, assessment, prevention, and therapy of endometriosis
PT1761779E (pt) * 2004-08-13 2008-02-01 Indivumed Gmbh Utilização de transtirretina como um biomarcador de adenoma colorrectal; método de detecção e sistema de teste
ES2334671T3 (es) 2004-08-13 2010-03-15 Egomedical Technologies Ag Sistema de ensayo de analitos para determinar la concentracion de un analito en un fluido fisiologico o acuoso.
US9075062B2 (en) 2005-03-22 2015-07-07 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Identification of biomarkers by serum protein profiling

Also Published As

Publication number Publication date
IL181131A0 (en) 2007-07-04
EP1776587B9 (en) 2009-09-16
IL181132A (en) 2011-04-28
PT1776587E (pt) 2009-04-03
ES2322378T3 (es) 2009-06-19
JP4916441B2 (ja) 2012-04-11
AU2004322162A1 (en) 2006-02-16
DK1761779T3 (da) 2008-02-25
WO2006053592A1 (en) 2006-05-26
JP2008509409A (ja) 2008-03-27
SI1776587T1 (sl) 2009-06-30
ES2295907T3 (es) 2008-04-16
ATE419534T1 (de) 2009-01-15
ATE376674T1 (de) 2007-11-15
BRPI0419002A (pt) 2007-12-11
AU2004322162B2 (en) 2011-04-28
MX2007001479A (es) 2007-07-25
DE602005012108D1 (de) 2009-02-12
CN101014859A (zh) 2007-08-08
JP4592753B2 (ja) 2010-12-08
PL1776587T3 (pl) 2009-06-30
IL181131A (en) 2011-03-31
JP2008509407A (ja) 2008-03-27
US7883842B2 (en) 2011-02-08
EP1776587A1 (en) 2007-04-25
MX2007001254A (es) 2007-10-05
PT1761779E (pt) 2008-02-01
EP1843159A1 (en) 2007-10-10
DE602004009716D1 (de) 2007-12-06
EP1776587B1 (en) 2008-12-31
CA2576998A1 (en) 2006-05-26
AU2005306103A1 (en) 2006-05-26
EP1761779B1 (en) 2007-10-24
ZA200701188B (en) 2009-01-28
NO20070598L (no) 2007-05-14
AU2004322162A2 (en) 2006-02-16
KR20070051328A (ko) 2007-05-17
US20080160515A1 (en) 2008-07-03
CN101014861A (zh) 2007-08-08
NO20070599L (no) 2007-05-14
CA2577601A1 (en) 2006-02-16
WO2006015616A1 (en) 2006-02-16
IL181132A0 (en) 2007-07-04
PL1761779T3 (pl) 2008-04-30
US20070184499A1 (en) 2007-08-09
EP1761779A1 (en) 2007-03-14
DE602004009716T2 (de) 2008-08-28
US7951528B2 (en) 2011-05-31

Similar Documents

Publication Publication Date Title
DK1776587T3 (da) Anvendelse af C3a og derivater deraf som biomarkör for colorektalt adenom og/eller carcinom, diagnosemetoder og assays under anvendelse deraf
BRPI0519119A2 (pt) sistema colorimÉtrico e mÉtodo para detectar um analito
ATE556030T1 (de) Ultrasensitiver nachweis von analyten
WO2010033371A3 (en) Molecular markers for lung and colorectal carcinomas
WO2009058902A3 (en) Methods and devices for analyte detection
WO2006073811A3 (en) Fluorescence detection system
JP2015514987A5 (da)
BRPI0814201A2 (pt) Sistema e método de análise de produto de análise em amostra fluida e meio legível em computador
WO2005041893A3 (en) Detection of acute myocardial infarction biomarkers
ATE527543T1 (de) Testvorrichtung zur schnelldiagnose
CA2701341A1 (en) Method of assessing colorectal cancer from a stool sample by use of the marker combination calprotectin and hemoglobin/haptoglobin complex
WO2008109075A3 (en) Biomarkers and methods for determining sensitivity to ctla-4 antagonists
ATE370414T1 (de) Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs
JP2020514689A5 (da)
WO2015077382A3 (en) Combined cytology and molecular testing for early detection of esophageal adenocarcinoma
AR058900A1 (es) Metodo para determinar la identidad o no identidad y la concentracion de un compuesto quimico en un medio
EP1924710A4 (en) METHOD FOR DIAGNOSIS OF AN OVARIAN CARCINOMA AND KIT THEREFOR
IL189185A0 (en) Use of an endoplasmin fragment and derivatives thereof as a biomarker for colorectal adenoma and/or carcinoma; method for detection and test system
WO2009063249A3 (en) Early detection of sepsis
CY1113013T1 (el) Βελτιωμενες μεθοδοι ανοσολογικων δοκιμασιων
DE602006015702D1 (de) Unterscheidung zwischen baktiereller meningitis und viraler meningitis
DK1416278T3 (da) Fremgangsmåder til forbedret diagnosticering af dysplasier
MX2023006922A (es) Ensayo de flujo lateral para deteccion de monensina.
EP2017642A3 (fr) Procédé et dispositif de détection et de mesure de paramètres de signaux radioélectriques
MX2017008959A (es) Biomarcadores relacionados con la funcion del riñon y metodos que involucran su uso.